The Alnylam Pharmaceuticals, Inc. (ALNY) gross profit margin is 85.6%, compared to the industry median of 78.2% and the 5-year historical average of 84.1%.
The Alnylam Pharmaceuticals, Inc. (ALNY) operating income margin is (16.8%), compared to the industry median of (129.8%)) and the 5-year historical average of (108.5%).
The Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow margin is (1.9%), compared to the industry median of (114.4%) and the 5-year historical average of (74.3%).
The Alnylam Pharmaceuticals, Inc. (ALNY) earnings quality is 15.3%, compared to the industry median of 86.6% and the 5-year historical average of 26.6%.